General Hospital Psychiatry
Volume 27, Issue 2 , Pages 148-150 , March 2005

Fluvoxamine induced complex partial seizure in the treatment of bulimia nervosa

Received 14 June 2004 ,Accepted 30 November 2004.

References 

  1. Pope HG, Hudson JI, Jonas JM, Yurgelum Todd D. Bulimia treated with imipramine; a placebo-controlled, double-blind study. Am. J. Psychiatry. 1983;140:554–558
  2. Mitchell JE, Groat R. A placebo-controlled, double-blind trial of amitriptyline in bulimia. J. Clin. Psychopharmacol. 1984;4:186–193
  3. Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Arch. Gen. Psychiatry. 1992;49:139–147
  4. Fichter MM, Kruger R, Rief W, Holland R, Dohne J. Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating-specific psychopathology. J. Clin. Psychopharmacol. 1996;16:9–18
  5. Rosenstein DL, Nelson JC, Jacobs SC. Seizures associated with antidepressants: a review. J. Clin. Psychiatry. 1993;54:289–299
  6. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 4th ed.. Washington (DC): APA; 1994;
  7. Krijzer F, Snelder M, Bradford D. Comparison of the (pro)convulsive properties of fluvoxamine and cluvoxamine with eight other antidepressants in an animal model. Neuropsychobiology. 1984;12:249–254
  8. Harmant J, van Rijckevorsel-Harmant K, de Barsy T, et al. Fluvoxamine: an antidepressant with low (or no) epileptogenic effect. Lancet. 1990;336:386
  9. Weber JJ. Seizure activity associated with fluoxetine therapy. Clin. Pharmacol. 1998;8:296–298
  10. Ware MR, Stewart RB. Seizures associated with fluoxetine therapy. DICP, Ann. Psychopharmacother. 1989;23:628
  11. Deahl M, Trimple M. Serotonin reuptake inhibitors, epilepsy and myoclonus. Br. J. Psychiatry. 1991;159:433–435
  12. Trabert W, Hohagen F, Winkelmann G, Berger M. A seizure, and electroencephalographic signs of a lowered seizure threshold, associated with fluvoxamine treatment of obsessive–compulsive disorder. Pharmacopsychiatry. 1995;28:95–97

PII: S0163-8343(04)00144-6

doi: 10.1016/j.genhosppsych.2004.11.006

General Hospital Psychiatry
Volume 27, Issue 2 , Pages 148-150 , March 2005

Article Tools

* Image Usage & Resolution